Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 14:23:34 UTC
Update Date2021-09-26 23:09:20 UTC
HMDB IDHMDB0254910
Secondary Accession NumbersNone
Metabolite Identification
Common NameMozavaptan
DescriptionN-{4-[5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carbonyl]phenyl}-2-methylbenzamide belongs to the class of organic compounds known as benzanilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with a benzene ring. They have the general structure RNC(=O)R', where R,R'= benzene. N-{4-[5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carbonyl]phenyl}-2-methylbenzamide is a very strong basic compound (based on its pKa). This compound has been identified in human blood as reported by (PMID: 31557052 ). Mozavaptan is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Mozavaptan is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
PhysulineMeSH
5-dimethylamino-1-(4-(2-methylbenzoylamino)Benzoyl)-2,3,4,5-tetrahydro-1H-benzazepineMeSH
MozavaptanMeSH
Chemical FormulaC27H29N3O2
Average Molecular Weight427.548
Monoisotopic Molecular Weight427.225977186
IUPAC NameN-{4-[5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carbonyl]phenyl}-2-methylbenzamide
Traditional Namemozavaptan
CAS Registry NumberNot Available
SMILES
CN(C)C1CCCN(C(=O)C2=CC=C(NC(=O)C3=CC=CC=C3C)C=C2)C2=CC=CC=C12
InChI Identifier
InChI=1S/C27H29N3O2/c1-19-9-4-5-10-22(19)26(31)28-21-16-14-20(15-17-21)27(32)30-18-8-13-24(29(2)3)23-11-6-7-12-25(23)30/h4-7,9-12,14-17,24H,8,13,18H2,1-3H3,(H,28,31)
InChI KeyWRNXUQJJCIZICJ-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as benzanilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with a benzene ring. They have the general structure RNC(=O)R', where R,R'= benzene.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassAnilides
Direct ParentBenzanilides
Alternative Parents
Substituents
  • Benzanilide
  • Benzazepine
  • Benzamide
  • Benzoic acid or derivatives
  • O-toluamide
  • Toluamide
  • Benzoyl
  • Azepine
  • Toluene
  • Aralkylamine
  • Tertiary carboxylic acid amide
  • Amino acid or derivatives
  • Carboxamide group
  • Secondary carboxylic acid amide
  • Tertiary amine
  • Tertiary aliphatic amine
  • Carboxylic acid derivative
  • Organoheterocyclic compound
  • Azacycle
  • Organooxygen compound
  • Organonitrogen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Organic nitrogen compound
  • Amine
  • Organic oxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Not AvailableNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP4.26ALOGPS
logP4.94ChemAxon
logS-5.2ALOGPS
pKa (Strongest Acidic)13.83ChemAxon
pKa (Strongest Basic)8.49ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area52.65 ŲChemAxon
Rotatable Bond Count4ChemAxon
Refractivity131.04 m³·mol⁻¹ChemAxon
Polarizability48.23 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M-2H]-237.45230932474
DeepCCS[M+Na]+212.68130932474
AllCCS[M+H]+208.732859911
AllCCS[M+H-H2O]+206.332859911
AllCCS[M+NH4]+210.932859911
AllCCS[M+Na]+211.532859911
AllCCS[M-H]-205.932859911
AllCCS[M+Na-2H]-206.332859911
AllCCS[M+HCOO]-207.032859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
MozavaptanCN(C)C1CCCN(C(=O)C2=CC=C(NC(=O)C3=CC=CC=C3C)C=C2)C2=CC=CC=C124753.3Standard polar33892256
MozavaptanCN(C)C1CCCN(C(=O)C2=CC=C(NC(=O)C3=CC=CC=C3C)C=C2)C2=CC=CC=C123739.3Standard non polar33892256
MozavaptanCN(C)C1CCCN(C(=O)C2=CC=C(NC(=O)C3=CC=CC=C3C)C=C2)C2=CC=CC=C123783.3Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Mozavaptan,1TMS,isomer #1CC1=CC=CC=C1C(=O)N(C1=CC=C(C(=O)N2CCCC(N(C)C)C3=CC=CC=C32)C=C1)[Si](C)(C)C3496.1Semi standard non polar33892256
Mozavaptan,1TMS,isomer #1CC1=CC=CC=C1C(=O)N(C1=CC=C(C(=O)N2CCCC(N(C)C)C3=CC=CC=C32)C=C1)[Si](C)(C)C3293.9Standard non polar33892256
Mozavaptan,1TMS,isomer #1CC1=CC=CC=C1C(=O)N(C1=CC=C(C(=O)N2CCCC(N(C)C)C3=CC=CC=C32)C=C1)[Si](C)(C)C4436.1Standard polar33892256
Mozavaptan,1TBDMS,isomer #1CC1=CC=CC=C1C(=O)N(C1=CC=C(C(=O)N2CCCC(N(C)C)C3=CC=CC=C32)C=C1)[Si](C)(C)C(C)(C)C3733.3Semi standard non polar33892256
Mozavaptan,1TBDMS,isomer #1CC1=CC=CC=C1C(=O)N(C1=CC=C(C(=O)N2CCCC(N(C)C)C3=CC=CC=C32)C=C1)[Si](C)(C)C(C)(C)C3500.7Standard non polar33892256
Mozavaptan,1TBDMS,isomer #1CC1=CC=CC=C1C(=O)N(C1=CC=C(C(=O)N2CCCC(N(C)C)C3=CC=CC=C32)C=C1)[Si](C)(C)C(C)(C)C4475.8Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Mozavaptan GC-MS (Non-derivatized) - 70eV, Positivesplash10-00kr-0952200000-77854e272bd039bdebe22021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Mozavaptan GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mozavaptan 10V, Positive-QTOFsplash10-004i-0422900000-9971438643dc46cf31382016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mozavaptan 20V, Positive-QTOFsplash10-014i-0941200000-8efa0a1720af95787b8d2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mozavaptan 40V, Positive-QTOFsplash10-014i-6920000000-ff6d7c5f12e18da758b32016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mozavaptan 10V, Negative-QTOFsplash10-004i-0001900000-59b962e0700e0fa855462016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mozavaptan 20V, Negative-QTOFsplash10-004i-3443900000-9ba20db0c16bcd02e1062016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mozavaptan 40V, Negative-QTOFsplash10-0006-8932000000-e0129717c923b5dcb6e72016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mozavaptan 10V, Positive-QTOFsplash10-004i-0000900000-e4254f70aad64fdb0e982021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mozavaptan 20V, Positive-QTOFsplash10-00ou-5812900000-c0913e3276531b5d680a2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mozavaptan 40V, Positive-QTOFsplash10-0006-9200000000-67258c2e287d7235cf172021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mozavaptan 10V, Negative-QTOFsplash10-004i-1000900000-4aae4df3bccbbcfbd36c2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mozavaptan 20V, Negative-QTOFsplash10-002f-8112900000-0d7b4391f2c39c36b07f2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mozavaptan 40V, Negative-QTOFsplash10-0006-9523200000-b95ed9638472b8be7d192021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound119369
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]